Works matching IS 03618609 AND DT 2025 AND VI 100 AND IP 3

Results: 29
    1
    2

    Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 427, doi. 10.1002/ajh.27582
    By:
    • Ntanasis‐Stathopoulos, Ioannis;
    • Filippatos, Charalampos;
    • Ntanasis‐Stathopoulos, Anastasios;
    • Malandrakis, Panagiotis;
    • Kastritis, Efstathios;
    • Tsitsilonis, Ourania E.;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    3
    4
    5
    6
    7

    Hyper‐CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome‐Negative B‐Cell Acute Lymphoblastic Leukemia.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 402, doi. 10.1002/ajh.27576
    By:
    • Kantarjian, Hagop;
    • Short, Nicholas J.;
    • Jain, Nitin;
    • Haddad, Fadi G.;
    • Kadia, Tapan;
    • Yilmaz, Musa;
    • Ferrajoli, Alessandra;
    • Sasaki, Koji;
    • Alvarado, Yesid;
    • Pemmaraju, Naveen;
    • Senapati, Jayastu;
    • Garris, Rebecca;
    • Ravandi, Farhad;
    • Jabbour, Elias
    Publication type:
    Article
    8
    9
    10
    11

    Unlocking Sanctuary Sites: The Efficacy of Brexucabtagene Autoleucel in Ocular B‐ALL Relapse.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 483, doi. 10.1002/ajh.27572
    By:
    • Calabretta, Ludovica;
    • Zappasodi, Patrizia;
    • Di Biase, Carlo;
    • Picone, Cristina;
    • Roncoroni, Elisa;
    • Rossi, Marianna;
    • Bianchessi, Antonio;
    • Defrancesco, Irene;
    • Zerbi, Caterina;
    • Ferrari, Beatrice;
    • Consensi, Erica;
    • Martini, Gianluca;
    • Tobar Cabrera, Claudia Patricia;
    • Battista, Claudia;
    • Mazzacane, Alessandro;
    • Romano, Francesco;
    • Losi, Giulia;
    • Taurino, Alessia;
    • Arcaini, Luca;
    • Polverelli, Nicola
    Publication type:
    Article
    12
    13
    14
    15
    16

    Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA‐EPIFLUEHA Report.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 358, doi. 10.1002/ajh.27565
    By:
    • Salmanton‐García, Jon;
    • Marchesi, Francesco;
    • Navrátil, Milan;
    • Piukovics, Klára;
    • del Principe, Maria Ilaria;
    • Criscuolo, Marianna;
    • Bilgin, Yavuz M.;
    • Fracchiolla, Nicola S.;
    • Vena, Antonio;
    • Romano, Alessandra;
    • Falces‐Romero, Iker;
    • Sgherza, Nicola;
    • Heras‐Fernando, Inmaculada;
    • Biernat, Monika M.;
    • Petzer, Verena;
    • Žák, Pavel;
    • Weinbergerová, Barbora;
    • Samarkos, Michail;
    • Erben, Nurettin;
    • van Praet, Jens
    Publication type:
    Article
    17

    Treatment Effectiveness of Venetoclax‐Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real‐World Study.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 511, doi. 10.1002/ajh.27563
    By:
    • Ghosh, Nilanjan;
    • Eyre, Toby A.;
    • Brown, Jennifer R.;
    • Lamanna, Nicole;
    • Manzoor, Beenish S.;
    • Coombs, Catherine C.;
    • Tuncer, Hande H.;
    • Ujjani, Chaitra;
    • Leslie, Lori A.;
    • Roeker, Lindsey E.;
    • Davids, Matthew S.;
    • Rhodes, Joanna M.;
    • Skarbnik, Alan P.;
    • Sinai, Wendy;
    • Fleury, Isabelle;
    • Hill, Brian T.;
    • Martinez‐Calle, Nicolas;
    • Barr, Paul M.;
    • Jawaid, Dureshahwar;
    • Emechebe, Nnadozie
    Publication type:
    Article
    18
    19
    20
    21
    22

    Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 507, doi. 10.1002/ajh.27553
    By:
    • Guerineau, Hippolyte;
    • Cayuela, Jean‐Michel;
    • Dulucq, Stéphanie;
    • Tran Quang, Violaine;
    • Tarfi, Sihem;
    • Gricourt, Guillaume;
    • Barathon, Quentin;
    • Joy, Corine;
    • Wagner‐Ballon, Orianne;
    • Morisset, Stéphane;
    • Nicolini, Frank‐Emmanuel;
    • Brunet, Erika;
    • Maury, Sébastien;
    • Roy, Lydia;
    • Etienne, Gabriel;
    • Réa, Delphine;
    • Sloma, Ivan
    Publication type:
    Article
    23
    24
    25
    26

    Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 439, doi. 10.1002/ajh.27539
    By:
    • Cooper, Nichola;
    • Jansen, A. J. Gerard;
    • Bird, Robert;
    • Mayer, Jiří;
    • Sholzberg, Michelle;
    • Tarantino, Michael D.;
    • Garg, Mamta;
    • Ypma, Paula F.;
    • McDonald, Vickie;
    • Percy, Charles;
    • Košťál, Milan;
    • Goncalves, Isaac;
    • Bogdanov, Lachezar H.;
    • Gernsheimer, Terry B.;
    • Diab, Remco;
    • Yao, Mengjie;
    • Daak, Ahmed;
    • Kuter, David J.
    Publication type:
    Article
    27
    28
    29

    Issue Information.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 355, doi. 10.1002/ajh.27390
    Publication type:
    Article